Moody Lynn & Lieberson LLC Has $29.52 Million Stock Position in Stryker Corporation $SYK

Moody Lynn & Lieberson LLC cut its holdings in Stryker Corporation (NYSE:SYK) by 6.8% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 83,991 shares of the medical technology company’s stock after selling 6,081 shares during the period. Stryker makes up approximately 1.6% of Moody Lynn & Lieberson LLC’s investment portfolio, making the stock its 18th largest position. Moody Lynn & Lieberson LLC’s holdings in Stryker were worth $29,520,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in Stryker by 0.8% in the 3rd quarter. Vanguard Group Inc. now owns 33,773,399 shares of the medical technology company’s stock valued at $12,485,012,000 after purchasing an additional 272,828 shares during the period. State Street Corp increased its holdings in shares of Stryker by 1.0% during the second quarter. State Street Corp now owns 14,956,732 shares of the medical technology company’s stock worth $5,929,765,000 after purchasing an additional 150,204 shares during the period. Alliancebernstein L.P. raised its position in shares of Stryker by 13.3% in the third quarter. Alliancebernstein L.P. now owns 6,338,050 shares of the medical technology company’s stock valued at $2,342,987,000 after buying an additional 741,542 shares in the last quarter. Legal & General Group Plc raised its position in shares of Stryker by 4.4% in the third quarter. Legal & General Group Plc now owns 2,303,290 shares of the medical technology company’s stock valued at $851,457,000 after buying an additional 96,662 shares in the last quarter. Finally, Corient Private Wealth LLC boosted its stake in shares of Stryker by 104.4% in the second quarter. Corient Private Wealth LLC now owns 2,245,841 shares of the medical technology company’s stock valued at $887,525,000 after buying an additional 1,146,998 shares during the period. 77.09% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Stryker news, Director Ronda E. Stryker sold 250,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total value of $90,730,000.00. Following the sale, the director owned 2,457,331 shares in the company, valued at $891,814,566.52. This trade represents a 9.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 5.20% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

SYK has been the topic of a number of recent research reports. UBS Group lowered their price objective on Stryker from $400.00 to $380.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 17th. Sanford C. Bernstein upped their target price on Stryker from $450.00 to $465.00 and gave the company an “outperform” rating in a research report on Friday, January 9th. Barclays reissued an “overweight” rating and set a $469.00 target price on shares of Stryker in a report on Monday, February 2nd. Evercore set a $390.00 price target on Stryker in a research report on Monday, January 5th. Finally, Needham & Company LLC boosted their price target on Stryker from $448.00 to $454.00 and gave the company a “buy” rating in a research note on Friday, January 30th. Fourteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, Stryker has a consensus rating of “Moderate Buy” and a consensus price target of $427.50.

Stryker Stock Performance

NYSE:SYK opened at $328.34 on Wednesday. Stryker Corporation has a twelve month low of $319.32 and a twelve month high of $404.87. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66. The stock’s 50-day simple moving average is $358.77 and its 200 day simple moving average is $362.73. The firm has a market capitalization of $125.75 billion, a PE ratio of 39.09, a price-to-earnings-growth ratio of 1.91 and a beta of 0.85.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, topping analysts’ consensus estimates of $4.40 by $0.07. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The firm had revenue of $7.17 billion during the quarter, compared to analysts’ expectations of $7.12 billion. During the same quarter in the prior year, the business earned $4.01 earnings per share. The business’s revenue for the quarter was up 11.4% compared to the same quarter last year. On average, analysts anticipate that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be paid a $0.88 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 annualized dividend and a yield of 1.1%. Stryker’s dividend payout ratio is presently 41.90%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.